Rhumbline Advisers trimmed its position in Brighthouse Financial, Inc. (NASDAQ:BHF - Free Report) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 163,021 shares of the company's stock after selling 4,707 shares during the quarter. Rhumbline Advisers owned approximately 0.27% of Brighthouse Financial worth $7,831,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in the company. Joel Isaacson & Co. LLC bought a new stake in shares of Brighthouse Financial in the 4th quarter valued at approximately $643,000. Lecap Asset Management Ltd. increased its holdings in shares of Brighthouse Financial by 9.1% in the 4th quarter. Lecap Asset Management Ltd. now owns 5,234 shares of the company's stock valued at $251,000 after acquiring an additional 436 shares during the last quarter. Institute for Wealth Management LLC. bought a new stake in shares of Brighthouse Financial in the 4th quarter valued at approximately $287,000. KBC Group NV increased its holdings in shares of Brighthouse Financial by 33.1% in the 4th quarter. KBC Group NV now owns 2,664 shares of the company's stock valued at $128,000 after acquiring an additional 663 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in shares of Brighthouse Financial in the 4th quarter valued at approximately $312,000. 81.24% of the stock is currently owned by institutional investors.
Insider Activity
In other news, EVP Myles Lambert sold 8,400 shares of the company's stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $51.70, for a total value of $434,280.00. Following the completion of the sale, the executive vice president now owns 33,407 shares in the company, valued at $1,727,141.90. This represents a 20.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP John Rosenthal sold 10,000 shares of the company's stock in a transaction on Friday, January 31st. The shares were sold at an average price of $61.00, for a total value of $610,000.00. Following the completion of the sale, the executive vice president now owns 66,262 shares of the company's stock, valued at approximately $4,041,982. This trade represents a 13.11 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.40% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on BHF. Wells Fargo & Company upgraded Brighthouse Financial from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $41.00 to $59.00 in a research note on Wednesday, February 19th. Barclays upgraded Brighthouse Financial from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $52.00 to $85.00 in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods upped their price objective on Brighthouse Financial from $60.00 to $66.00 and gave the stock a "market perform" rating in a research note on Tuesday, February 18th. Jefferies Financial Group downgraded Brighthouse Financial from a "buy" rating to a "hold" rating and set a $64.00 price objective for the company. in a research note on Monday, February 3rd. Finally, Piper Sandler upped their price objective on Brighthouse Financial from $52.00 to $60.00 and gave the stock a "neutral" rating in a research note on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Brighthouse Financial currently has a consensus rating of "Hold" and a consensus target price of $63.14.
Get Our Latest Stock Report on Brighthouse Financial
Brighthouse Financial Stock Performance
BHF stock traded up $0.61 during trading on Friday, reaching $59.31. 1,421,481 shares of the company's stock were exchanged, compared to its average volume of 768,612. The company has a quick ratio of 0.92, a current ratio of 0.93 and a debt-to-equity ratio of 0.63. Brighthouse Financial, Inc. has a 1-year low of $40.00 and a 1-year high of $64.12. The company's fifty day moving average price is $54.25 and its 200-day moving average price is $49.54. The firm has a market cap of $3.52 billion, a PE ratio of 11.49 and a beta of 1.10.
Brighthouse Financial (NASDAQ:BHF - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The company reported $5.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.56 by $1.32. Brighthouse Financial had a return on equity of 26.94% and a net margin of 8.21%. On average, research analysts expect that Brighthouse Financial, Inc. will post 20.32 EPS for the current fiscal year.
Brighthouse Financial Profile
(
Free Report)
Brighthouse Financial, Inc provides annuity and life insurance products in the United States. It operates through three segments: Annuities, Life, and Run-off. The Annuities segment consists of variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security.
Featured Articles

Before you consider Brighthouse Financial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brighthouse Financial wasn't on the list.
While Brighthouse Financial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.